Calling Regulators’ Bluff
26:32–27:08 · 36s
Celgene ignores federal demands to share its drug, keeps competitors out, and internally boasts it can charge whatever cancer patients will pay.
26:32–27:08 · 36s
Celgene ignores federal demands to share its drug, keeps competitors out, and internally boasts it can charge whatever cancer patients will pay.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.